Multiple-dose applications of rotigotine transdermal patch to evaluate the pharmacokinetics, safety, and tolerability in healthy subjects.

被引：0
|
作者：
Kim, B. H. [1 ]
Lim, K. S. [1 ]
Kim, J. W. [1 ]
Kim, M. G. [1 ]
Kim, T. E. [1 ]
Chung, Y. J. [1 ]
Yu, K. S. [1 ]
Shin, S. G. [1 ]
Jang, I. J. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med & Hosp, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S25 / S26
页数：2
相关论文
共 50 条
  • [1] Evaluation of safety, tolerability, and multiple-dose pharmacokinetics of istradefylline in healthy subjects.
    Rao, N.
    Uchimura, T.
    Mori, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S99 - S99
  • [2] Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration
    Willi Cawello
    Seong Ryul Kim
    Marina Braun
    Jan-Peer Elshoff
    Takeuchi Masahiro
    Junji Ikeda
    Tomoo Funaki
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 353 - 362
  • [3] Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration
    Cawello, Willi
    Kim, Seong Ryul
    Braun, Marina
    Elshoff, Jan-Peer
    Masahiro, Takeuchi
    Ikeda, Junji
    Funaki, Tomoo
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (04) : 353 - 362
  • [4] Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
    Cawello, Willi
    Kim, Seong R.
    Braun, Marina
    Elshoff, Jan-Peer
    Ikeda, Junji
    Funaki, Tomoo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 95 - 105
  • [5] Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
    Willi Cawello
    Seong R. Kim
    Marina Braun
    Jan-Peer Elshoff
    Junji Ikeda
    Tomoo Funaki
    Clinical Drug Investigation, 2014, 34 : 95 - 105
  • [6] MULTIPLE-DOSE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, IN HEALTHY JAPANESE AND CAUCASIAN SUBJECTS.
    Sidharta, P.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S43 - S44
  • [7] Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects
    Hu, Chaoying
    Wang, Yijun
    Song, Rong
    Yu, Chen
    Luo, Xiaoyan
    Jia, Jingying
    CLINICAL DRUG INVESTIGATION, 2017, 37 (09) : 861 - 871
  • [8] Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects
    Chaoying Hu
    Yijun Wang
    Rong Song
    Chen Yu
    Xiaoyan Luo
    Jingying Jia
    Clinical Drug Investigation, 2017, 37 : 861 - 871
  • [9] Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy Subjects
    Modi, Nishit B.
    Dinh, Phillip
    Ajari, Ifode
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025,
  • [10] Multiple-dose pharmacokinetics, pharmacodynamics, safety, and tolerability of the orexin receptor antagonist almorexant in healthy subjects
    Hoever, P.
    de Haas, S.
    Chiossi, E.
    van Gerven, J.
    Dingemanse, J.
    SLEEP, 2008, 31 : A38 - A38
12345